XDH and chronic kidney disease: Our recent study further showed that in the presence of chronic renal insufficiency, hydralazine could enhance the in vitro EPC function and improve in vivo ischemia-induced neovasculogenesis via xanthine oxidase (XO) and NADPH oxidase inhibition [11].